Shi Qing Cheng
Direktor/Vorstandsmitglied bei Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Profil
Shi Qing Cheng is currently the Vice Chairman at Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Prior to this, he graduated from Peking University with a graduate degree in 1999 and from Renmin University of China with an undergraduate degree in 1982.
Aktive Positionen von Shi Qing Cheng
Unternehmen | Position | Beginn |
---|---|---|
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 18.11.2021 |
Ausbildung von Shi Qing Cheng
Peking University | Graduate Degree |
Renmin University of China | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
Health Technology |